These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 33109071)

  • 1. A cross-sectional study on the burden and impact of migraine on work productivity and quality of life in selected workplaces in the Philippines.
    Haw NJ; Cabaluna IT; Kaw GE; Cortez JF; Chua MP; Guce K
    J Headache Pain; 2020 Oct; 21(1):125. PubMed ID: 33109071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of migraine on workplace productivity and monetary loss: a study of employees in banking sector in Malaysia.
    Wong LP; Alias H; Bhoo-Pathy N; Chung I; Chong YC; Kalra S; Shah ZUBS
    J Headache Pain; 2020 Jun; 21(1):68. PubMed ID: 32513174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disability, quality of life, productivity impairment and employer costs of migraine in the workplace.
    Shimizu T; Sakai F; Miyake H; Sone T; Sato M; Tanabe S; Azuma Y; Dodick DW
    J Headache Pain; 2021 Apr; 22(1):29. PubMed ID: 33882816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Employee and Employer Benefits From a Migraine Management Program: Disease Outcomes and Cost Analysis.
    Schaetz L; Rimner T; Pathak P; Fang J; Chandrasekhar D; Mueller J; Sandor PS; Gantenbein AR
    Headache; 2020 Oct; 60(9):1947-1960. PubMed ID: 32799346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health care Resource Utilization and Migraine Disability Along the Migraine Continuum Among Patients Treated for Migraine.
    Silberstein SD; Lee L; Gandhi K; Fitzgerald T; Bell J; Cohen JM
    Headache; 2018 Nov; 58(10):1579-1592. PubMed ID: 30375650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Annual indirect costs savings in patients with episodic or chronic migraine: a post-hoc analysis of phase 3 galcanezumab clinical trials in the United States.
    Varnado OJ; Ye W; Mi X; Burge R; Hall J
    J Med Econ; 2023; 26(1):149-157. PubMed ID: 36601798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Headache-Free Days on Disability, Productivity, Quality of Life, and Costs Among Individuals with Migraine.
    Lipton RB; Lee L; Saikali NP; Bell J; Cohen JM
    J Manag Care Spec Pharm; 2020 Oct; 26(10):1344-1352. PubMed ID: 32678720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients' perspective on the burden of migraine in Europe: a cross-sectional analysis of survey data in France, Germany, Italy, Spain, and the United Kingdom.
    Vo P; Fang J; Bilitou A; Laflamme AK; Gupta S
    J Headache Pain; 2018 Sep; 19(1):82. PubMed ID: 30203163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of resource utilization and cost burden before and after an employer-based migraine education program.
    Page MJ; Paramore LC; Doshi D; Rupnow MF
    J Occup Environ Med; 2009 Feb; 51(2):213-20. PubMed ID: 19209043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Need for care and perceptions of MIDAS among headache sufferers study.
    Stewart W; Lipton R
    CNS Drugs; 2002; 16 Suppl 1():5-11. PubMed ID: 12196034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. My Migraine Voice survey: disease impact on healthcare resource utilization, personal and working life in Finland.
    Sumelahti ML; Sumanen M; Sumanen MS; Tuominen S; Vikkula J; Honkala SM; Rosqvist S; Korolainen MA
    J Headache Pain; 2020 Sep; 21(1):118. PubMed ID: 32993489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A global real-world assessment of the impact on health-related quality of life and work productivity of migraine in patients with insufficient versus good response to triptan medication.
    Lombard L; Farrar M; Ye W; Kim Y; Cotton S; Buchanan AS; Jackson J; Joshi S
    J Headache Pain; 2020 Apr; 21(1):41. PubMed ID: 32349662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of sumatriptan on workplace productivity, nonwork activities, and health-related quality of life among hospital employees with migraine.
    Mushet GR; Miller D; Clements B; Pait G; Gutterman DL
    Headache; 1996 Mar; 36(3):137-43. PubMed ID: 8984084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Four-year review of presenteeism data among employees of a large United States health care system: a retrospective prevalence study.
    Allen D; Hines EW; Pazdernik V; Konecny LT; Breitenbach E
    Hum Resour Health; 2018 Nov; 16(1):59. PubMed ID: 30413168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of a worksite migraine intervention program on work productivity, productivity costs, and non-workplace impairment among Spanish postal service employees from an employer perspective.
    Vicente-Herrero T; Burke TA; Laínez MJ
    Curr Med Res Opin; 2004 Nov; 20(11):1805-14. PubMed ID: 15537481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. United States Patients' Perspective of Living With Migraine: Country-Specific Results From the Global "My Migraine Voice" Survey.
    Gibbs SN; Shah S; Deshpande CG; Bensink ME; Broder MS; Dumas PK; Buse DC; Vo P; Schwedt TJ
    Headache; 2020 Jul; 60(7):1351-1364. PubMed ID: 32369201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct and Indirect Healthcare Resource Utilization and Costs Among Migraine Patients in the United States.
    Bonafede M; Sapra S; Shah N; Tepper S; Cappell K; Desai P
    Headache; 2018 May; 58(5):700-714. PubMed ID: 29446063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic impact of migraine and other episodic headaches in France: data from the GRIM2000 study.
    Pradalier A; Auray JP; El Hasnaoui A; Alzahouri K; Dartigues JF; Duru G; Henry P; Lantéri-Minet M; Lucas C; Chazot G; Gaudin AF
    Pharmacoeconomics; 2004; 22(15):985-99. PubMed ID: 15449963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burden of migraine among Japanese patients: a cross-sectional National Health and Wellness Survey.
    Kikui S; Chen Y; Todaka H; Asao K; Adachi K; Takeshima T
    J Headache Pain; 2020 Sep; 21(1):110. PubMed ID: 32912187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validity of the ID-Migraine screener in the workplace.
    Siva A; Zarifoglu M; Ertas M; Saip S; Karli HN; Baykan B; Keskinaslan A; Senocak M
    Neurology; 2008 Apr; 70(16):1337-45. PubMed ID: 18413587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.